HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jaeduk Yoshimura Noh Selected Research

Methimazole (Thiamazole)

10/2015Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
1/2015Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
5/2014Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
1/2013The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
8/2009Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.
6/2007Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
12/2006[Treatment with inorganic iodine for Graves' hyperthyroidism].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jaeduk Yoshimura Noh Research Topics

Disease

9Graves Disease (Basedow Disease)
10/2015 - 12/2006
4Hyperthyroidism
10/2015 - 12/2006
4Thyroid Neoplasms (Thyroid Cancer)
01/2014 - 07/2006
3Thyroid Diseases (Thyroid Disease)
01/2015 - 01/2011
3Thyrotoxicosis
01/2015 - 11/2012
3Vasculitis (Vasculitides)
01/2014 - 08/2009
2Thyroid Nodule (Nodule, Thyroid)
01/2015 - 07/2013
2Thyroiditis
01/2015 - 11/2012
2Agranulocytosis (Granulocytopenia)
05/2014 - 01/2014
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2013 - 08/2009
1Fetal Diseases (Embryopathy)
10/2015
1Lymphoma (Lymphomas)
06/2014
1Subacute Thyroiditis (Thyroiditis, De Quervain)
11/2012
1Infection
01/2012
1Pituitary Neoplasms (Pituitary Adenoma)
01/2012
1Neoplasms (Cancer)
10/2008
1Neoplasm Metastasis (Metastasis)
11/2007
1Carcinoma (Carcinomatosis)
07/2006

Drug/Important Bio-Agent (IBA)

7Methimazole (Thiamazole)FDA LinkGeneric
10/2015 - 12/2006
5PropylthiouracilFDA Link
05/2014 - 12/2006
4Antithyroid Agents (Antithyroid Drugs)IBA
10/2015 - 08/2009
4IodineIBA
10/2015 - 12/2006
4HormonesIBA
01/2015 - 12/2006
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2014 - 08/2009
2Factor IX (PTC)FDA LinkGeneric
07/2013 - 07/2006
2papillary Thyroid cancerIBA
07/2013 - 10/2008
2Peroxidase (Myeloperoxidase)IBA
01/2013 - 08/2009
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
10/2009 - 03/2009
1Potassium Iodide (Pima)FDA Link
10/2015
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2015
1rituximab (Mabthera)FDA Link
06/2014
1AntigensIBA
07/2013
1Biological Markers (Surrogate Marker)IBA
07/2013
1Complementary DNA (cDNA)IBA
07/2013
1thyrotropin-binding inhibitory immunoglobulinIBA
11/2012
1SteroidsIBA
01/2012
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2012
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2011
1AntibodiesIBA
01/2011
1AutoantibodiesIBA
03/2009
1ThyroglobulinFDA Link
11/2007
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
06/2007

Therapy/Procedure

2Thyroidectomy
04/2014 - 11/2007